Are you Dr. Pinchasik?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3705 5th Ave
Pittsburgh, PA 15213Phone+1 412-638-5325
Summary
- Dr. Dawn Pinchasik, MD is a pediatric hematologist/oncologist in Pittsburgh, Pennsylvania. She is currently licensed to practice medicine in Ohio.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2010 - 2013
- UPMC Medical EducationResidency, Pediatrics, 2007 - 2010
- Drexel University College of MedicineClass of 2007
Certifications & Licensure
- OH State Medical License 2011 - 2014
Clinical Trials
- A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies Start of enrollment: 2014 Aug 01
- Safety and Tolerability of RTX-134 in Adults With Phenylketonuria Start of enrollment: 2020 Jan 29
Publications & Presentations
PubMed
- 64 citationsA randomized controlled clinical trial of real-time needle-guided ultrasound for internal jugular venous cannulation in a large university anesthesia departmentJohn G.T. Augoustides, Jiri Horak, Andrew E. Ochroch, William J. Vernick, Andrew J. Gambone
Journal of Cardiothoracic and Vascular Anesthesia. 2005-06-01 - 8 citationsPhysiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies.Ying Ou, Yang Xu, Lia Gore, R. Donald Harvey, Alain C. Mita
British Journal of Clinical Pharmacology. 2019-03-01 - 13 citationsA Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)Ralph V. Boccia, Alberto Bessudo, Richy Agajanian, Paul Conkling, Wael A. Harb
Clinical Lymphoma, Myeloma & Leukemia. 2017-07-01